These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39211552)

  • 41. Anatomic distribution, clinical features, and survival data of 87 cases primary gastrointestinal lymphoma.
    Ge Z; Liu Z; Hu X
    World J Surg Oncol; 2016 Mar; 14():85. PubMed ID: 26988370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Rituximab-Based Regimens for Treatment of Primary Gastric Diffuse Large B-Cell Lymphoma].
    Qu S; Liao LS; Zheng ZH; Xie Y; Chen WM; Chen BY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):760-764. PubMed ID: 35680802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Value of
    Jiang C; Teng Y; Chen J; Wang Z; Zhou Z; Ding C; Xu J
    Ann Nucl Med; 2020 Dec; 34(12):911-919. PubMed ID: 33057996
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group.
    Li X; Liu Z; Cao J; Hong X; Wang J; Chen F; Wang C; Zou S; Li J; Shen Z
    Ann Hematol; 2012 Jun; 91(6):837-45. PubMed ID: 22160255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prognostic significance of inflammatory indicators for advanced-stage diffuse large B-cell lymphoma].
    Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Sun Y; Shi YK
    Zhonghua Yi Xue Za Zhi; 2018 Apr; 98(16):1250-1255. PubMed ID: 29747314
    [No Abstract]   [Full Text] [Related]  

  • 46. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites.
    Wang C; Li W; Liu C; He H; Bai O
    Blood Cells Mol Dis; 2016 Mar; 57():42-9. PubMed ID: 26852654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Prognostic Model of Gastrointestinal Diffuse Large B Cell Lymphoma.
    Gao F; Wang ZF; Tian L; Dong F; Wang J; Jing HM; Ke XY
    Med Sci Monit; 2021 Aug; 27():e929898. PubMed ID: 34449759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytokine profiles in patients with newly diagnosed diffuse large B-cell lymphoma: IL-6 and IL-10 levels are associated with adverse clinical features and poor outcomes.
    Bao C; Gu J; Huang X; You L; Zhou Z; Jin J
    Cytokine; 2023 Sep; 169():156289. PubMed ID: 37453327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and validation of prognostic scoring in primary intestinal diffuse large B-cell lymphoma: a single-institution study of 184 patients.
    Fan X; Zang L; Zhao BB; Yi HM; Lu HY; Xu PP; Cheng S; Li QY; Fang Y; Wang L; Zhao WL
    Ann Transl Med; 2021 Oct; 9(20):1542. PubMed ID: 34790748
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Ki-67 proliferative index in non-Hodgkin's lymphoma and its clinical significance].
    Li J; Hu R; Liao AJ; Shi HY; Yan W; Liu ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):935-9. PubMed ID: 21867618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of the peripheral blood lymphocyte/monocyte ratio combined with
    Wu W; Zhao L; Wang Y; Chen P; Yuan X; Miao L; Zhu Y; Mao J; Cai Z; Ji Y; Wang L; Jia T
    Curr Probl Cancer; 2024 Feb; 48():101066. PubMed ID: 38364336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large B-Cell Lymphoma.
    Chen GL; Li D; Cao S; Jiang S; Zhang Q; Jin J; Xia Z; Liu Y; Liu X; Zhu Y; Chen Y; Gu L; Hong X; Cao J; Tao R; Lv F
    Mediterr J Hematol Infect Dis; 2022; 14(1):e2022066. PubMed ID: 36119461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Values of Different Evaluation Criteria of Interim
    Zhu LT; Cen XN; Ou JP; Qiu ZX; Wang LH; Liu W; Wang WS; Dong YJ; Liang ZY; Wang MJ; Xu WL; Sun YH; Wang Q; Yin Y; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):431-437. PubMed ID: 28446288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A comparative study of induction chemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed young medium/high risk diffuse large B cell lymphoma patients].
    Wang X; Xia B; Wang CY; Li MZ; Xu W; Yuan T; Tian C; Zhao HF; Yang HL; Zhao ZG; Wang XF; Wang YF; Yu Y; Zhang YZ
    Zhonghua Xue Ye Xue Za Zhi; 2019 Feb; 40(2):117-124. PubMed ID: 30831626
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical characteristics of 46 pediatric diffuse large B-cell lymphoma and treatment outcome].
    Huang S; Yang J; Jin L; Duan YL; Zhang M; Zhang NN; Li Q; Zhang N; Zhou CJ; Zhang YH
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):774-779. PubMed ID: 31594064
    [No Abstract]   [Full Text] [Related]  

  • 56. Factors affecting survival in elderly patients with diffuse large B-Cell lymphoma.
    Ulu BU; Yiğenoğlu TN; Başcı S; Bakırtaş M; Şahin D; Darçın T; Yaman S; Bozan E; Seçilmiş S; Candır BA; Yıldız J; İskender D; Baysal NA; Çakar MK; Dal MS; Altuntaş F
    Leuk Res; 2021 Nov; 110():106700. PubMed ID: 34481125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic tumour area: a novel prognostic indicator based on
    Cui S; Xin W; Wang F; Shao X; Shao X; Niu R; Zhang F; Shi Y; Liu B; Gu W; Wang Y
    BMC Cancer; 2024 Jul; 24(1):895. PubMed ID: 39054508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor.
    Bairey O; Shacham-Abulafia A; Shpilberg O; Gurion R
    Hematol Oncol; 2016 Dec; 34(4):184-192. PubMed ID: 26052918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beta2-microglobulin is a valuable marker and identifies a poor-prognosis subgroup among intermediate-risk patients with diffuse large B cell lymphoma.
    Chen NC; Chang H; Kao HW; Ou CW; Kuo MC; Wang PN; Lin TL; Wu JH; Hung YS; Su YJ; Ong YC; Shih HJ
    Clin Exp Med; 2023 Nov; 23(7):3759-3766. PubMed ID: 37086332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low serum apolipoprotein A1 level predicts poor prognosis of patients with diffuse large B-cell lymphoma in the real world: a retrospective study.
    Huang X; Wang Y; Huang Z; Chen X; Lin Q; Huang H; Fan L
    BMC Cancer; 2024 Jan; 24(1):62. PubMed ID: 38212711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.